With the rise of heart disease and diabetes in India, the demand for cardiac and diabetic medicines has grown significantly. The PCD (Propaganda Cum Distribution) franchise model allows entrepreneurs to sell these medicines in a specific region with marketing support and exclusive territorial rights.
This business model is low-investment, high-return, helping improve healthcare access while creating profitable opportunities.
In this guide, we cover the top cardiac diabetic PCD companies in India, their products, benefits of joining a franchise, market trends, and tips for starting your PCD business.
A PCD pharma franchise allows a distributor to sell a company’s medicines in a defined territory. The company provides marketing materials, product training, and timely medicine supply.
The cardiac and diabetic segment is especially profitable because these conditions are chronic, requiring long-term medication. Patients continue to refill prescriptions, ensuring recurring revenue for franchise partners.
Partnering with a reputed PCD company also builds trust among doctors, hospitals, and patients. High-quality, GMP and WHO-certified medicines make it easier for new entrepreneurs to establish a credible business.
Cardiac and diabetic medicines are in constant demand across India. Tier-2 and tier-3 cities are now seeing more lifestyle-related health issues, which expands market opportunities.
Patients require long-term treatment, making the business sustainable. Companies are also innovating with combination drugs, nutraceuticals, and herbal supplements, offering franchise partners a wide range of products.
This segment provides high profit margins and a growing customer base, making it ideal for pharma entrepreneurs.
Meltic Group is a leading name in cardiac and diabetic medicines. The company is known for high-quality formulations, reliable supply, and GMP and WHO-certified products. Their portfolio includes anti-diabetic tablets, cardiac injections, lipid-lowering medicines, and heart supplements. Franchise partners enjoy exclusive territorial rights, timely supply, and marketing support.
Scott Morrison Pharma offers tablets, soft gels, and injectable medicines. Partners benefit from territorial monopoly rights, marketing assistance, and reliable supply. The company is recognized for quality products and strong franchise support.
Cardian Care provides anti-diabetic tablets, combination drugs, cardiac injections, and lipid-lowering medicines. Franchise partners get exclusive rights, marketing material, promotional support, and timely delivery.
Lifecare Cardio Diabetic offers tablets, capsules, injectable solutions, soft gels, and nutraceuticals. Partners receive exclusive territory rights, marketing support, and comprehensive training programs.
Arlak Corazon focuses on preventive and therapeutic cardiac and diabetic products. Their offerings include oral tablets, capsules, injectable cardiac medicines, and health supplements. Franchise partners enjoy monopoly rights, marketing assistance, and timely supply.
Cardiatic Care provides anti-diabetic tablets, cardiac injections, and lipid-lowering medicines. Franchise partners receive exclusive regional rights, marketing support, and uninterrupted supply.
Henin Lukinz offers tablets, syrups, injectables, and soft gel capsules. Partners enjoy regional monopoly rights, marketing assistance, and GMP-certified products.
Medibyte Pharma provides tablets, capsules, injectable solutions, and nutraceuticals. Franchise partners benefit from exclusive territory rights, marketing support, and timely supply.
Servocare Lifesciences specializes in anti-diabetic tablets, cardiac injections, and lipid-lowering medicines. Partners get monopoly rights, marketing assistance, and guaranteed supply.
Human Biolife India offers tablets, soft gels, capsules, injectable solutions, and heart and diabetes care supplements. Franchise partners enjoy exclusive regional rights, marketing support, and a reliable supply chain.
A: It is a business model where you sell cardiac and diabetic medicines in a defined territory with company support.
A: Investment usually ranges from ₹50,000 to ₹1,00,000 depending on the company and product range.
A: Yes, most companies provide exclusive territorial rights to reduce competition.
A: Yes, top companies provide brochures, product samples, and promotional assistance.
A: All products are GMP and WHO-certified, ensuring quality and patient safety.
The cardiac and diabetic PCD franchise business in India is profitable and scalable. Partnering with the top cardiac diabetic PCD companies in India, like Meltic Group, provides access to high-quality medicines, exclusive regional rights, and marketing support, enabling entrepreneurs to build a strong and credible business. Besides financial benefits, this business also improves healthcare access across urban and rural areas. With proper planning and consistent supply, a cardiac and diabetic PCD franchise offers a sustainable opportunity that combines profitability with social impact in India’s growing pharmaceutical sector.